Literature DB >> 1495966

Clonal evolution of a follicular lymphoma: evidence for antigen selection.

D W Bahler1, R Levy.   

Abstract

The potential role antigens play in growth stimulation or in clonal selection of follicular lymphomas is unknown. To study this issue, we sequenced the immunoglobulin heavy chain variable region genes expressed by a follicular lymphoma from multiple biopsy specimens and also cloned and sequenced the corresponding germ-line variable gene from this patient. Comparison to the germ-line gene revealed numerous nucleotide substitutions in all of the lymphoma variable gene sequences. Some of the substitutions may have occurred in the nonmalignant precursor B cell that gave rise to this lymphoma because they were shared among all of the variable genes, but many of the mutations accumulated as the malignant clone expanded. The mutations were distributed in such a way that strongly suggested the majority of tumor cells had been positively selected through their antigen receptor. This was especially evident for the mutations that developed late in the clonal evolution of this lymphoma. These findings indicate that antigen stimulation may be involved in the growth of follicular lymphoma tumors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495966      PMCID: PMC49585          DOI: 10.1073/pnas.89.15.6770

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas.

Authors:  L M Weiss; R A Warnke; J Sklar; M L Cleary
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

2.  Three-dimensional structure of an antigen-antibody complex at 6 A resolution.

Authors:  A G Amit; R A Mariuzza; S E Phillips; R J Poljak
Journal:  Nature       Date:  1985 Jan 10-18       Impact factor: 49.962

3.  A comprehensive set of sequence analysis programs for the VAX.

Authors:  J Devereux; P Haeberli; O Smithies
Journal:  Nucleic Acids Res       Date:  1984-01-11       Impact factor: 16.971

Review 4.  The normal and malignant germinal centre.

Authors:  H Stein; J Gerdes; D Y Mason
Journal:  Clin Haematol       Date:  1982-10

5.  Evolutionary nucleotide replacements in DNA.

Authors:  T H Jukes; J L King
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

6.  Somatic evolution of diversity among anti-phosphocholine antibodies induced with Proteus morganii.

Authors:  J L Claflin; J Berry; D Flaherty; W Dunnick
Journal:  J Immunol       Date:  1987-05-01       Impact factor: 5.422

7.  Restricted Ig variable region gene expression among Ly-1+ B cell lymphomas.

Authors:  C A Pennell; L W Arnold; G Haughton; S H Clarke
Journal:  J Immunol       Date:  1988-10-15       Impact factor: 5.422

8.  Retention of an idiotypic determinant in a human B-cell lymphoma undergoing immunoglobulin variable-region mutation.

Authors:  S Kon; S Levy; R Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

9.  Receptor mediated leukemogenesis: murine leukemia virus interacts with BCL1 lymphoma cell surface IgM.

Authors:  M S McGrath; G Tamura; I L Weissman
Journal:  J Mol Cell Immunol       Date:  1987

10.  Content and organization of the human Ig VH locus: definition of three new VH families and linkage to the Ig CH locus.

Authors:  J E Berman; S J Mellis; R Pollock; C L Smith; H Suh; B Heinke; C Kowal; U Surti; L Chess; C R Cantor
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

View more
  48 in total

Review 1.  Molecular definition of the germinal centre stage of B-cell differentiation.

Authors:  C Ma; L M Staudt
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-01-29       Impact factor: 6.237

2.  Clonal evolution of B cells in transformation from low- to high-grade lymphoma.

Authors:  A Matolcsy; E J Schattner; D M Knowles; P Casali
Journal:  Eur J Immunol       Date:  1999-04       Impact factor: 5.532

3.  Mutation analysis of IgVH gene in B-cell chronic lymphocytic leukemia.

Authors:  Feng Wang; Huifen Zhu; Lijuan Zhu; Botao Yin; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

4.  Splenic marginal zone lymphomas appear to originate from different B cell types.

Authors:  David W Bahler; J Ander Pindzola; Steven H Swerdlow
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

5.  Analysis of somatic hypermutation and antigenic selection in the clonal B cell in immunoglobulin light chain amyloidosis (AL).

Authors:  Roshini S Abraham; Susan M Geyer; Marina Ramírez-Alvarado; Tammy L Price-Troska; Morie A Gertz; Rafael Fonseca
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

6.  Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells.

Authors:  A Braeuninger; R Küppers; J G Strickler; H H Wacker; K Rajewsky; M L Hansmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

7.  Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.

Authors:  Z Szereday; B Csernus; M Nagy; T László; R A Warnke; A Matolcsy
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

Review 8.  Targeting the B-cell receptor signaling pathway in B lymphoid malignancies.

Authors:  Maike Buchner; Markus Müschen
Journal:  Curr Opin Hematol       Date:  2014-07       Impact factor: 3.284

Review 9.  The biology of human lymphoid malignancies revealed by gene expression profiling.

Authors:  Louis M Staudt; Sandeep Dave
Journal:  Adv Immunol       Date:  2005       Impact factor: 3.543

10.  Two acquired immunodeficiency syndrome-associated Burkitt's lymphomas produce specific anti-i IgM cold agglutinins using somatically mutated VH4-21 segments.

Authors:  P Riboldi; G Gaidano; E W Schettino; T G Steger; D M Knowles; R Dalla-Favera; P Casali
Journal:  Blood       Date:  1994-05-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.